Showing results (1-10 of 550) with videos related to
Sort By:
Pageof 55
Annual Review of Medicine|March 24, 1998
Adoptive immunotherapy following allogeneic bone marrow transplantationF Dazzi, J M GoldmanExperimental Hematology|October 12, 1999
Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant: where we now standF Dazzi, R M Szydlo, J M GoldmanThe Hematology Journal : the Official Journal of the European Haematology Association|March 29, 2002
Normal and chronic phase CML hematopoietic cells repopulate NOD/SCID bone marrow with different kinetics and cell lineage representationF Dazzi, R Hasserjian, M Y Gordon, et al.British Journal of Haematology|March 8, 2007
Factors for graft-versus-host disease after donor lymphocyte infusions with an escalating dose regimen: lack of association with cell doseC Fozza, R M Szydlo, M M Abdel-Rehim, et al.Blood|August 8, 1998
The kinetics and extent of engraftment of chronic myelogenous leukemia cells in non-obese diabetic/severe combined immunodeficiency mice reflect the phase of the donor's disease: an in vivo model of chronic myelogenous leukemia biologyF Dazzi, D Capelli, R Hasserjian, et al.Best Practice & Research. Clinical Haematology|April 24, 2007
Disease relapse after haematopoietic stem cell transplantation: risk factors and treatmentF Dazzi, C FozzaBritish Journal of Haematology|January 31, 1998
The rate and kinetics of molecular response to donor leucocyte transfusions in chronic myeloid leukaemia patients treated for relapse after allogeneic bone marrow transplantationP Raanani, F Dazzi, J Sohal, et al.Bone Marrow Transplantation|October 19, 2001
Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusionsK Cwynarski, R Goulding, C Pocock, et al.Pageof 55